Abstract
Two multidimensional problems of recent times — Alzheimer’s disease and light pollution — seem to be more interrelated than previously expected. A series of studies in years explore the pathogenesis and the course of Alzheimer’s disease, yet the mechanisms underlying this pathology remain not fully discovered and understood. Artificial lights which accompany civilization on a daily basis appear to have more detrimental effects on both environment and human health than previously anticipated. Circadian rhythm is affected by inappropriate lighting conditions in particular. The consequences are dysregulation of the sleep-wake cycle, gene expression, neuronal restructuring, brain’s electricity, blood flow, metabolites’ turnover, and gut microbiota as well. All these phenomena may contribute to neurodegeneration and consequently Alzheimer’s disease. There is an increasing number of research underlining the complexity of the correlation between light pollution and Alzheimer’s disease; however, additional studies to enhance the key tenets are required for a better understanding of this relationship.
Similar content being viewed by others
Introduction
The development of industry results in many environmental changes that can have a potentially negative impact on health. Light pollution is one of such industrialization’s side effects. About 80% of the population worldwide is influenced by excessive amounts of unnatural light [1]. Following the International Dark Sky Association, light pollution is the inappropriate or excessive use of artificial light that may cause serious environmental consequences for humans, wildlife, and climate. Most studies explore the influence of light at night and blue light on human health [2,3,4,5]. It is investigated that light pollution could affect many systems of the human body, and data indicate its indirect positive association with retina pathologies, cardiovascular damage, depression, cancer, and sleep disturbances [3, 6]. The latter shows the possible association with triggering neurodegeneration since sleep is essential for neurons to regenerate their plasticity and remove toxic compounds. In light pollution and its impact on neurodegeneration, the role of outdoor and indoor dim artificial light at night (dLAN) is noted [7, 8]. The dLAN strength is usually 5–10 lux which is also said to be the minimum quantity of light pollution in many countries [9]. It is discussed whether Alzheimer’s disease (AD) as a neurodegenerative disease may be induced by inappropriate artificial light [7, 8]. AD is one of the most common types of dementia and neurodegenerative disorders. Around the world, 55 million people have dementia, which will increase by 78 million in 2030 and 139 million in 2050 according to WHO [10]. Considering the significance of light pollution and AD, this review highlights the potential and multifaceted link between these two problems.
Light pollution’s influence on molecular mechanisms of neurodegeneration
An increasing number of studies emphasize the essential role of light in the course of neurodegenerative diseases (Table 1). The deregulation of circadian rhythms’ mechanisms may be responsible for this influence.
The physiological function and disruption of the circadian rhythm
Complex circadian timing systems are essential in most physiological processes in mammals, including sleep [8, 18]. The crucial elements of the molecular clock are remarkably evolutionary conserved, which might be a cause of their fundamental significance for life [8, 18]. The master pacemaker, located in the ventral hypothalamus’s suprachiasmatic nucleus (SCN), can synchronize complementary data from peripheral cells. The phase of the master clock must be periodically readjusted by light signals to keep it aligned with real geophysical time [8, 18]. In both SCN neurons and peripheral cells, the circadian clockwork is constructed from an interactive network of transcriptional and translational loops. The metabolism of neurotransmitters which take part in the mammalian circadian oscillator is regulated by the transcription factors such as albumin D-site-binding protein (DPB), hepatic leukemia factor (HLF), and thyrotroph embryonic factor (TEF). The system of circadian loops has yet to be fully discovered [19].
The micro and macro worlds follow the circadian rhythm of light and darkness. The development of artificial light sources disrupted the functioning of the inner clock. As a result, one of the most severe environmental threats may be light pollution, which could lead to chronic circadian desynchrony [8, 20].
Lucassen et al. investigated the health impact of continuous exposure to light. Mice were exposed to continuous light for 24 weeks, then major health parameters were measured. It has been shown that rhythmicity in the central circadian pacemaker of SCN was significantly reduced. Furthermore, reduction of skeletal muscle function, trabecular bone deterioration, and induction of a transient pro-inflammatory state have been observed. Research finally showed that after the mice were returned to a light-dark cycle, the SCN neurons recovered their normal high-amplitude rhythm, and the measured health parameters returned to normal [21]. The other study has determined that flies (drosophila melanogaster) maintained in daily cycles of 12-h blue LED and 12-h darkness had significantly reduced length of life compared with flies maintained in constant darkness or white light with blocked blue wave exposure. Moreover, it has been shown that blue-light exposure can accelerate aging phenotypes, damage retinal cells, cause brain neurodegeneration, and impair locomotion [12].
Evidence suggests that circadian rhythm disruption and connected sleep deprivation could be crucial risk factors for the development of AD [22,23,24]. Such individuals have a 1.49-fold higher risk of AD than subjects with no sleep and circadian disruptions [10]. It is suggested that the problem of light pollution may contribute to the relationship between artificial light and the development of neurodegenerative diseases.
Melatonin
A disrupted melatonin-releasing pattern could also play an important role in AD pathogenesis. This pineal gland’s hormone modulates the regulatory network of secretase expression and function [15, 25]. That may inhibit the amyloid precursor protein (APP) processing and Aβ production. Melatonin decreases Aβ-induced neurotoxicity and probably improves Aβ clearance via glymphatic-lymphatic and degradation pathways [15, 25]. It is hypothesized that melatonin restores cholinergic neurotransmission typically disrupted in AD [26]. The suggested mechanism inhibits the calcium-induced acetylcholinesterase (AChE) release, which may enhance acetylcholine acting [27]. Furthermore, melatonin is also recommended to alleviate the altered glutamatergic system in AD via inhibition of the N-methyl-D-aspartate receptor (NMDA) receptors [28]. Hypothetically, melatonin or potential melatonin receptor agonists could be a promising tool to prevent the accumulation of pathological proteins in AD [15, 25]. It is indicated in a recent meta-analysis that AD patients receiving >12 weeks of melatonin treatment improve their Mini Mental Scale Examination score [29].
Mechanisms of the influence of artificial light on the human organism
Two basic mechanisms are involved in adaptation to artificial light: image forming (IF) for vision and non-image forming (NIF) adaptation of physiology and behavior to light. NIF photoresponses are very varied and associated with the adjustment of pupil diameter, but also with slower responses, such as adaptation of the circadian clock to the daily day-night cycle. The cells responsible for NIF responses produce photopigment melanopsin and they are known as intrinsically photosensitive retinal ganglion cells (ipRGCs) [30, 31]. The role of ipRGCs is the integration of the pathways of phototransduction derived from the rod/cone and melanopsin actions. ipRGCs affect the SCN and other regions, including the intergeniculate leaflet of the thalamus, the olivary pretectal nucleus controlling pupil constriction, and structures engaged in emotions, cognition, or memory [32]. Important to highlight is that NIF responses have been found almost intact in experimental animals and blind human patients with complete degeneration of rod/cone photoreceptors [33, 34].
The invention of efficient and economically practical blue light-emitting diode (LED) changed daily lighting worldwide. The majority of the LED spectrum is blue light with 460 nm and this fraction is higher than in any other incandescent light [35]. The spectrum of ipRGCs and melanopsin action is the highest at 480 nm — the blue portion of light. Therefore, it is essential for NIF functions throughout the day and circadian synchronization. Inappropriate timing, intensity, or duration of blue light may yet result in circadian phase delay, melatonin suppression, sleep quality alteration, or reduction of cognitive performance [36]. It has been reported that the blue component of light could have a phototoxic effect on the retina since blue light presents the highest photon energy of the visible spectrum [37].
Circadian rhythm and CSF clearance from AD’s pathological proteins
Both sleep duration and quality are associated with Aβ cerebrospinal fluid (CSF) or interstitial fluid (ISF) concentration. Aβ levels in CSF show a diurnal pattern, increasing throughout the day, peaking at night, and decreasing overnight. It is suggested that the duration of wakefulness, instead of the circadian time point, is the factor affecting ISF-Aβ concentration [13]. The knowledge about the role of sleep and circadian rhythms in the brain protein clearance system is constantly increasing. In physiological conditions, Aβ and tau are either degraded by proteases or glial phagocytosis, or they may be transported out of the brain via ISF-CSF exchange by the glymphatic pathway or ISF-blood exchange by apolipoprotein E (ApoE) [14]. Under sleep deprivation, increased noradrenaline stimulation leads to swelling of the neurons. As a result of increased resistance, the CSF-ISF bulk flow is disrupted, inhibiting the delivery of ApoE. There is also a disturbance of the glymphatic pathway. These processes lead to impairment of the clearance of Aβ and tau out of the brain parenchyma. Furthermore, in prolonged waking and circadian rhythm disruption, orexin level keeps elevated and impairs phagocytic clearance of Aβ and tau [13, 24, 38] (Fig. 1).
Genetic aspects
Circadian rhythm disturbances connected with artificial light exposure may lead to neurodegenerative processes on the genetic level [9].
It was explored in a study performed on mice exposed to dLAN for 3 weeks. It led to the modulation of hippocampal protein expression coded by genes known to be associated with neurodegeneration — BDNF, CREB, DCX, SYN, and SIRT1. Disturbances in cognitive behavior occurred as a consequence of the exposure [9]. The additional downregulation of neurodegeneration-associated miRNA21a-5p and miRNA34a-5p could contribute to the abnormal behavior presented by mice [9].
Hui et al. exposed zebra finches to dim artificial light at night (ALAN) of 1.5 lux and analyzed 24 regions of the brain. In this study, the overall expression of two different IEGs (immediate early genes as a proxy of brain activity related to the response to dim ALAN) cFos and ZENK was used. IEG expression in birds exposed to ALAN was significantly different from birds inactive at night. The changes in expression concerned several brain areas associated with vision, movement, learning and memory, pain processing, and hormone regulation [17].
The circadian rhythm disruption may be caused by the deposition of pathological proteins in the brain [39]. The possible explanation of this relation is that Aβ triggers the deterioration of circadian clock proteins BMAL1 and CREB-binding Protein (CBP), causing changes in the expression of circadian clock genes BMAL1 and Period Circadian Regulator 2 (PER2) with consequences of a disturbed sleep-wake cycle [39]. Recent studies also suggest that the accumulation of tau aggregates is related to decreased nonrapid eye movement (NREM) sleep slow wave activity [40]. In the presence of tau, cyclic expression of the circadian clock proteins PER2 and BMALI1 is interrupted in both the hippocampus and the hypothalamus, confirming tau’s detrimental effect on the circadian rhythm [22]. Experimental deletion and reduction of expression of the BMAL1 gene in the cortex and hippocampus induced severe reactive astrocytosis, neuronal oxidative damages, and the degeneration of synaptic terminals. It suggests that changed circadian functions could be responsible for developing neurodegeneration through lowered BMAL1 [11] (Fig. 2).
Defensive mechanisms of Aβ clearance in CSF are also related to the circadian clock’s genes. The presenile-2 protein (PSEN-2) is expressed in the presence of clock genes Clock Circadian Regulator (CLOCK) and BMAL1. PSEN-2 is responsible for the cleavage of, e.g., Aβ and thus diminishes its level in the brain. In the hereditary type of AD, the PSEN-2 gene is muted, resulting in a reverse effect than in the physiological state, accumulation of Aβ, and neurodegeneration [41, 42] (Fig. 2).
One in 3 days of exposure to dLAN may promote neurodegeneration in AD models. According to this study, the tauopathy/AD flies after dLAN exposure presented an altered circadian rhythm, which led to an increased number of pTau proteins and neurodegeneration levels [16]. It was then suggested that dLAN could exacerbate neurodegenerative disease, including AD, among AD model, flies [16].
The indirect influence of light pollution on AD and other neurodegenerative diseases
Light pollution may affect neurodegeneration through changes in levels of lipids in the blood, vessel structure, or gut microbiota among others. It is suggested that artificial light also impacts neurodegenerative diseases other than AD (Table 2).
Obesity and cardiovascular system
Indirect influences of light could explain the relation between light pollution and neurodegeneration. Research suggests that light pollution may contribute to obesity and overall higher cardiometabolic risk. Geographically and historically, there is a coincidence between the appearance of obesity and the availability of artificial light. Experimental studies on both animals and humans underline the role of disturbances in the circadian rhythm as a convergence between light pollution and obesity [8]. The association between light, circadian rhythm, and cardiometabolic risk in turn was observed in the study on the effects of post-bedtime and pre-awake dLAN in the bedrooms of Chinese teenagers. It presented that exposure to light after bedtime might be related to elevated fasting insulin and HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) while pre-awake light to elevated total cholesterol, triglyceride, and low-density lipoprotein cholesterol (LDL) [49]. It is well-known and confirmed in multiple studies that cardiometabolic risk factors, including obesity, support neurodegeneration [50, 51]. It could be then suggested that light pollution through interruption of the sleep-wake cycle and metabolic changes consequently may contribute to the development of neurodegenerative disorders, including AD.
Vascular dysfunction is another aspect that connects circadian rhythm and AD. It occurs that human cerebral blood flow velocity is under the control of circadian rhythm, but it is independent of circadian changes in locomotor activity or blood pressure [52]. The risk of AD is characterized by hypometabolism and cerebral hypoperfusion as well [43]. Hypothetically, alterations in circadian rhythm may cause vascular and blood flow changes that contribute to AD development, yet it must be fully confirmed.
Microbiota
There is also growing evidence of the role of gut microbiota in the occurrence of AD. The circadian rhythm seems to regulate the gut microbiota. Circadian functions when disturbed could induce changes in microbiota structure. This bacterial alteration, especially the loss of intestinal microbiota, may lead to the greater permeability of the gut barrier and consequently systemic inflammation with impairment in the blood-brain barrier and neuroinflammation as well [53,54,55]. Furthermore, the composition of gut microbiota in AD patients resembles the microbiome after changes in circadian rhythm [44].
Other types of dementia
MCI as a state between normal cognitive aging and early dementia as well as a known risk factor for AD seems to also be triggered by dLAN. It has been discovered that Chinese veterans, exposed for a long term to outdoor dLAN, presented a higher risk of developing MCI. This might suggest that light pollution in some cases plays a role in developing AD from the earliest stages [7].
Studies indicate that the development of AD could be related to dementia with Lewy bodies (DLB) pathogenesis with the role of a disrupted sleep-wake cycle. Since Lewy bodies may exist in the brains of 60% of AD sporadic individuals, it is possible that also through these neurodegenerative structures, circadian dysfunction contributes to the course of AD [45, 56, 57].
Studies also assessed the influence of light pollution on neurodegenerative diseases other than AD. Such a relation is determined for both Parkinson’s (PD) and Huntington’s disease (HD) so far. The prevalence of PD when age- and race-adjusted is significantly correlated with average satellite-observed skylight pollution [46]. Another study might explain this correlation in the molecular aspects. Rats exposed to bright light (3000 lux) presented higher levels of neuromelatonin neurons and lower levels of tyrosine hydroxylase (TH)-positive neurons in the substantia nigra which suggested oxidative stress in this region caused by light [47]. In HD, the detrimental effect of the light may be associated with disrupting the circadian rhythm. HD mice models exposed to dLAN (20 lux) show worsening HD symptoms due to dysregulated sleep-wake cycle [48].
Potential problem-solving strategies
Efforts are underway to design our living areas with lighting that is more compatible with our biology. This is beneficial from the socio-economic, ecological, and health perspectives [58]. However, until some of these practices become widespread, individuals are still exposed to environmental light pollution. Nevertheless, daily routine changes and indoor light exposure are significant. It was shown that the bright light presence in the morning and reduced light exposure during the evenings could increase sleep quality and reduce agitation in patients with dementia [59,60,61].
Another aspect of this topic is that in many electrical light bulbs used today and considered “environmentally friendly,” such as light-emitting diodes (LEDs) devices, electrical energy is converted into short-wavelength illumination. LEDs illuminate industrial environments in TVs, computers, smartphones, and tablets. Although the light emitted by most LEDs appears white, LEDs have peak emission in the blue light range (400–490 nm), which could be one of the leading causes of disruption of circadian rhythms [62]. Moreover, studies show that blue light may decrease human melatonin levels and cause response delays and depressive-like emotions in mice [63, 64]. In this case, a healthier alternative may be a blue-free WLED (white light-emitting diode) that can avoid chronodisruption [20].
Environmental and technological light pollution leads to disturbances in the functioning of the biological clock and its subsequent effects. Therefore, it is possible that the circadian rhythm’s normalizing, especially rest-activity patterns, will benefit people with AD. In that case, bright light therapy seems an exciting tool, often administered to treat circadian rhythm disturbances [23, 65, 66]. It is shown that appropriate protocols of bright light therapy can positively affect cognitive functions, length, and quality of sleep, reduce symptoms of depression, and improve appetite in patients with dementia [67, 68]. These results pave the way for further research and the creation of new optimal therapeutic protocols. Moreover, the positive effects of using the optimal lighting pattern could be used in facilities that care for people with AD [65].
Final remarks and conclusions
dLAN seems to be the most important type of light pollution that may contribute to neurodegeneration. Exposure to dLAN could lead to the modulation of hippocampal protein expression and the intensification of oxidative stress, sleep disturbances, and dysregulation of the biological clock [9, 16, 69,70,71]. Under circadian rhythm disruption, there is a more significant accumulation of neurotoxic proteins such as tau or Aβ. These proteins are not adequately removed from the brain via glial phagocytosis or active transport [13, 24, 25, 38, 42]. The impact of circadian rhythm disruption on BMI, vascular disorders, gut microbiota dysfunction, and neuroinflammation could take part in the pathogenesis of the AD [43, 44, 52, 54, 55]. Therefore, it seems possible that normalizing the rest-activity pattern, through the reduction of light pollution, among others, would be one of the protective factors in the development of neurodegeneration. Examples of such actions include using appropriate artificial lighting patterns or bright light therapy [20, 66].
Additional studies to understand more completely the key tenets of light pollution on human health are required. Especially the long-term effects of extensive blue light in LEDs on the human body remain to be analyzed. It needs be noted that research should contain not only light intensity but also its wavelength as well as temporal and spatial resolution in light measurements. The mechanistic aspects of light pollution’s influence on the body’s functioning should also be explored in detail in future studies. Possibly more research on humans instead of animal models would present more relevant results in the context of medicine, so far deficiency in the scientific literature.
The extent and intensity of artificial night lighting increase so much that it has substantial effects on the biology of individuals, leading to the development of various pathological conditions. A lot of indirect evidence indicates that light pollution can affect the development of many neurodegenerative diseases, including AD. More extensive broad-spectrum studies are needed for a better understanding of the multifaceted connection between AD and light pollution to create a balanced model of everyday artificial lightning.
References
Falchi F, Cinzano P, Duriscoe D, Kyba CCM, Elvidge CD, Baugh K, et al. The new world atlas of artificial night sky brightness. Sci Adv. 2016. https://doi.org/10.1126/sciadv.1600377.
Fonken LK, Nelson RJ. Effects of light exposure at night during development. Curr Opin Behav Sci. 2016;7:33–9.
Helbich M, Browning MHEM, Huss A. Outdoor light at night, air pollution and depressive symptoms: a cross-sectional study in the Netherlands. Sci Total Environ. 2020;744:140914.
Maggio R, Vaglini F, Rossi M, Fasciani I, Pietrantoni I, Marampon F, et al. Parkinson’s disease and light: the bright and the dark sides. Brain Res Bull. 2019;150:290–6.
Walker WH, Borniger JC, Gaudier-Diaz MM, Hecmarie Meléndez-Fernández O, Pascoe JL, Courtney DeVries A, et al. Acute exposure to low-level light at night is sufficient to induce neurological changes and depressive-like behavior. Mol Psychiatry. 2020;25:1080–93.
Münzel T, Hahad O, Daiber A. The dark side of nocturnal light pollution. Outdoor light at night increases risk of coronary heart disease. Eur Heart J. 2021;42:831.
Chen Y, Tan J, Liu Y, Dong GH, Yang BY, Li N, et al. Long-term exposure to outdoor light at night and mild cognitive impairment: a nationwide study in Chinese veterans. Sci Total Environ. 2022;847:157441.
Wyse CA, Selman C, Page MM, Coogan AN, Hazlerigg DG. Circadian desynchrony and metabolic dysfunction; did light pollution make us fat? Med Hypotheses. 2011;77:1139–44.
Namgyal D, Chandan K, Sultan A, Aftab M, Ali S, Mehta R, et al. Dim light at night induced neurodegeneration and ameliorative effect of curcumin. Cells. 2020;9:2093.
Shi L, Chen SJ, Ma MY, Bao YP, Han Y, Wang YM, et al. Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med Rev. 2018;40:4–16.
Musiek ES, Lim MM, Yang G, Bauer AQ, Qi L, Lee Y, et al. Circadian clock proteins regulate neuronal redox homeostasis and neurodegeneration. J Clin Invest. 2013;123:5389–400.
Nash TR, Chow ES, Law AD, Fu SD, Fuszara E, Bilska A, et al. Daily blue-light exposure shortens lifespan and causes brain neurodegeneration in Drosophila. NPJ Aging Mech Dis. 2019. https://doi.org/10.1038/s41514-019-0038-6.
Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326:1005–7.
Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol. 2015;11:457–70.
Li Y, Zhang J, Wan J, Liu A, Sun J. Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: a potential therapeutic molecule for Alzheimer’s disease. Biomed Pharmacother. 2020;132:10887.
Kim M, Subramanian M, Cho YH, Kim GH, Lee E, Park JJ. Short-term exposure to dim light at night disrupts rhythmic behaviors and causes neurodegeneration in fly models of tauopathy and Alzheimer’s disease. Biochem Biophys Res Commun. 2018;495:1722–9.
Hui CK, Chen N, Chakraborty A, Alaasam V, Pieraut S, Ouyang JQ. Dim artificial light at night alters immediate early gene expression throughout the avian brain. Front Neurosci. 2023;17:1194996.
Schibler U. The daily rhythms of genes, cells and organs. Biological clocks and circadian timing in cells. EMBO Rep. 2005;6:9–13.
Gachon F, Fonjallaz P, Damiola F, Gos P, Kodama T, Zakany J, et al. The loss of circadian PAR bZip transcription factors results in epilepsy. Genes Dev. 2004;18:1397–412.
Menéndez-Velázquez A, Morales D, García-Delgado AB. Light pollution and circadian misalignment: a healthy, blue-free, white light-emitting diode to avoid chronodisruption. Int J Environ Res Public Health. 2022;19:1849.
Lucassen EA, Coomans CP, Guigas B, Aartsma-Rus AM, Meijer JH. Environmental 24-hr cycles are essential for health. Curr Biol. 2016;26:1843–53.
Uddin MS, Sumsuzzman DM, Jeandet P, Behl T, Rauf A, Amran MS, et al. Deciphering the interacting mechanisms of circadian disruption and Alzheimer’s disease. Neurochem Res. 2021;46:1603–17.
Saeed Y, Abbott SM. Circadian disruption associated with Alzheimer’s disease. Curr Neurol Neurosci Rep. 2017;17(4):29.
Wu H, Dunnett S, Ho YS, Chang RCC. The role of sleep deprivation and circadian rhythm disruption as risk factors of Alzheimer’s disease. Front Neuroendocrinol. 2019;54:100764.
Slats D, Claassen JAHR, Verbeek MM, Overeem S. Reciprocal interactions between sleep, circadian rhythms and Alzheimer’s disease: focus on the role of hypocretin and melatonin. Ageing Res Rev. 2013;12:188–200.
Roy J, Tsui KC, Ng J, Fung ML, Lim LW. Regulation of melatonin and neurotransmission in Alzheimer’s disease. Int J Mol Sci. 2021;22:6841.
Shukla M, Govitrapong P, Boontem P, Reiter RJ, Satayavivad J. Mechanisms of melatonin in alleviating Alzheimer’s disease. Curr Neuropharmacol. 2017;15:1010.
Shi Y, Fang YY, Wei YP, Jiang Q, Zeng P, Tang N, et al. Melatonin in synaptic impairments of Alzheimer’s disease. J Alzheimers Dis. 2018;63:911–26.
Sumsuzzman DM, Choi J, Jin Y, Hong Y. Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer’s disease and insomnia: a systematic review and meta-analysis of randomized controlled trials. Neurosci Biobehav Rev. 2021;127:459–73.
Hatori M, Panda S. The emerging roles of melanopsin in behavioral adaptation to light. Trends Mol Med. 2010;16:435.
Hatori M, Gronfier C, Van Gelder RN, Bernstein PS, Carreras J, Panda S, et al. Global rise of potential health hazards caused by blue light-induced circadian disruption in modern aging societies. npj Aging Mech Dis. 2017;3:1.
Hattar S, Kumar M, Park A, Tong P, Tung J, Yau KW, et al. Central projections of melanopsin-expressing retinal ganglion cells in the mouse. J Comp Neurol. 2006;497:326.
Wee R, Van Gelder RN. Sleep disturbances in young subjects with visual dysfunction. Ophthalmology. 2004;111:297–302.
Gooley JJ, Rajaratnam SMW, Brainard GC, Kronauer RE, Czeisler CA, Lockley SW. Spectral responses of the human circadian system depend on the irradiance and duration of exposure to light. Sci Transl Med. 2010;2:31ra33.
Tsao JY, Coltrin ME, Crawford MH, Simmons JA. Solid-state lighting: an integrated human factors, technology, and economic perspective. Proc IEEE. 2010;98:1162–79.
Chang AM, Aeschbach D, Duffy JF, Czeisler CA. Evening use of light-emitting eReaders negatively affects sleep, circadian timing, and next-morning alertness. Proc Natl Acad Sci USA. 2015;112:1232–7.
Narimatsu T, Ozawa Y, Miyake S, Kubota S, Yuki K, Nagai N, et al. Biological effects of blocking blue and other visible light on the mouse retina. Clin Exp Ophthalmol. 2014;42:555–63.
Yulug B, Hanoglu L, Kilic E. Does sleep disturbance affect the amyloid clearance mechanisms in Alzheimer’s disease? Psychiatry Clin Neurosci. 2017;71:673–7.
Song H, Moon M, Choe HK, Han DH, Jang C, Kim A, et al. Aβ-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer’s disease. Mol Neurodegener. 2015;10:1–15.
Wang C, Holtzman DM. Bidirectional relationship between sleep and Alzheimer’s disease: role of amyloid, tau, and other factors. Neuropsychopharmacology. 2020;45:104–20.
Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science. 1995;269:973–7.
Bélanger V, Picard N, Cermakian N. The circadian regulation of Presenilin-2 gene expression. Chronobiol Int. 2006;23:747–66.
Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, et al. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer’s disease among patients with mild cognitive impairment. Neurobiol Aging. 2011;32:15–23.
Liu P, Wu L, Peng G, Han Y, Tang R, Ge J, et al. Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort. Brain Behav Immun. 2019;80:633–43.
Hamilton RL. Lewy bodies in Alzheimer’s disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 2000;10:378–84.
Wright Willis A, Evanoff BA, Lian M, Criswell SR, Racette BA. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 2010;34:143–51.
Romeo S, Viaggi C, Di Camillo D, Willis AW, Lozzi L, Rocchi C, et al. Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson’s disease epidemiology. Sci Rep. 2013;3:1.
Wang HB. Photo-environment affects disease progression in bacterial artificial chromosome(BAC) Huntington’s disease mouse model. Los Angeles: University of California; 2015.
Xu YX, Yu Y, Huang Y, Wan YH, Su PY, Tao FB, et al. Exposure to bedroom light pollution and cardiometabolic risk: a cohort study from Chinese young adults. Environ Pollut. 2022;294:118628.
Cavaliere F, Gülöksüz S. Shedding light on the etiology of neurodegenerative diseases and dementia: the exposome paradigm. npj Ment Health Res. 2022;1:20.
Mazon JN, de Mello AH, Ferreira GK, Rezin GT. The impact of obesity on neurodegenerative diseases. Life Sci. 2017;182:22–8.
Conroy DA, Spielman AJ, Scott RQ. Daily rhythm of cerebral blood flow velocity. J Circadian Rhythms. 2005;3:3.
Askarova S, Umbayev B, Masoud AR, Kaiyrlykyzy A, Safarova Y, Tsoy A, et al. The links between the gut microbiome, aging, modern lifestyle and Alzheimer’s disease. Front Cell Infect Microbiol. 2020;10:104.
Kowalski K, Mulak A. Brain-gut-microbiota axis in Alzheimer’s disease. J Neurogastroenterol Motil. 2019;25:48–60.
Liang X, Bushman FD, FitzGerald GA. Rhythmicity of the intestinal microbiota is regulated by gender and the host circadian clock. Proc Natl Acad Sci USA. 2015;112:10479–84.
McKeith IG, Burn D. Spectrum of Parkinson’s disease, Parkinson’s dementia, and Lewy body dementia. Neurol Clin. 2000;18:865–83.
McKeith IG, Dickson DW, Lowe J, Emre M, O’Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 2005;65:1863–72.
Lapostolle D, Challéat S. Making darkness a place-based resource: how the fight against light pollution reconfigures rural areas in France. Ann Am Assoc Geogr. 2020;111:196–215.
van Lieshout-van DE, Snaphaan L, Bongers I. Biodynamic lighting effects on the sleep pattern of people with dementia. Build Environ. 2019;150:245–53.
Zielinska-Dabkowska KM, Xavia K. An overview of the cognitive and biological effects of city nighttime illumination including a London case study. In: Conscious Cities Anthology 2018 Human-Centered Design, Science, and Technology. London, UK: The Centre for Conscious Design; 2018.
Gfigueiro MG, Plitnick BA, Lok A, Ejones GE, Higgins P, Rhornick TR, et al. Tailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer’s disease and related dementia living in long-term care facilities. Clin Interv Aging. 2014;9:1527.
Tosini G, Ferguson I, Tsubota K. Effects of blue light on the circadian system and eye physiology. Mol Vis. 2016;22:61.
West KE, Jablonski MR, Warfield B, Cecil KS, James M, Ayers MA, et al. Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans. J Appl Physiol. 2011;110:619–26.
Wu F, Wu S, Gui Q, Tang K, Xu Q, Tao Y, et al. Blue light insertion at night is involved in sleep and arousal-promoting response delays and depressive-like emotion in mice. Biosci Rep. 2021;41:20204033.
Hanford N, Figueiro M. Light therapy and Alzheimer’s disease and related dementia: past, present, and future. J Alzheimers Dis. 2013;33:913.
Roccaro I, Smirni D. Fiat lux: the light became therapy. An overview on the bright light therapy in Alzheimer’s disease sleep disorders. J Alzheimers Dis. 2020;77:113–25.
Dowling GA, Graf CL, Hubbard EM, Luxenberg JS. Light treatment for neuropsychiatric behaviors in Alzheimer’s disease. West J Nurs Res. 2007;29:961–75.
Graf A, Wallner C, Schubert V, Willeit M, Wlk W, Fischer P, et al. The effects of light therapy on mini-mental state examination scores in demented patients. Biol Psychiatry. 2001;50:725–7.
Goel N, Basner M, Rao H, Dinges DF. Circadian rhythms, sleep deprivation, and human performance. Prog Mol Biol Transl Sci. 2013;119:155–90.
Cao M, Xu T, Yin D. Understanding light pollution: recent advances on its health threats and regulations. J Environ Sci. 2023;127:589–602.
Tähkämö L, Partonen T, Pesonen AK. Systematic review of light exposure impact on human circadian rhythm. Chronobiol Int. 2019;36:151–70.
Acknowledgements
The authors would like to acknowledge the Faculty of Medicine, Department of Psychiatry, Department of Health Sciences, and Department of Pulmonology and Lung Oncology at the Wroclaw Medical University and Hirszfeld Institute of Immunology and Experimental Therapy at the Polish Academy of Sciences.
Author information
Authors and Affiliations
Contributions
Conceptualization, J.L; methodology, J.K, Sz.K.; investigation, J.K, Sz.K.; data curation, J.K, Sz.K.; writing — original draft preparation, J.K, Sz.K.; writing — review and editing, J.L., A.G., A.B., D.K.; supervision, J.L., A.G., A.B., D.K.; project administration, J.L.; funding acquisition, J.L. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Karska, J., Kowalski, S., Gładka, A. et al. Artificial light and neurodegeneration: does light pollution impact the development of Alzheimer’s disease?. GeroScience 46, 87–97 (2024). https://doi.org/10.1007/s11357-023-00932-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11357-023-00932-0